515 related articles for article (PubMed ID: 27038189)
1. Brain imaging of neurovascular dysfunction in Alzheimer's disease.
Montagne A; Nation DA; Pa J; Sweeney MD; Toga AW; Zlokovic BV
Acta Neuropathol; 2016 May; 131(5):687-707. PubMed ID: 27038189
[TBL] [Abstract][Full Text] [Related]
2. Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging.
van de Haar HJ; Jansen JFA; van Osch MJP; van Buchem MA; Muller M; Wong SM; Hofman PAM; Burgmans S; Verhey FRJ; Backes WH
Neurobiol Aging; 2016 Sep; 45():190-196. PubMed ID: 27459939
[TBL] [Abstract][Full Text] [Related]
3. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
Tosun D; Schuff N; Jagust W; Weiner MW;
Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Resonance Imaging of Blood-Brain Barrier permeability in Dementia.
Chagnot A; Barnes SR; Montagne A
Neuroscience; 2021 Oct; 474():14-29. PubMed ID: 34400249
[TBL] [Abstract][Full Text] [Related]
5. Decoupling of Regional Cerebral Blood Flow and Brain Function Along the Alzheimer's Disease Continuum.
Li J; Zeng Q; Luo X; Li K; Liu X; Hong L; Zhang X; Zhong S; Qiu T; Liu Z; Chen Y; Huang P; Zhang M;
J Alzheimers Dis; 2023; 95(1):287-298. PubMed ID: 37483006
[TBL] [Abstract][Full Text] [Related]
6. Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease.
Yan L; Liu CY; Wong KP; Huang SC; Mack WJ; Jann K; Coppola G; Ringman JM; Wang DJJ
Neuroimage Clin; 2018; 17():751-760. PubMed ID: 29527482
[TBL] [Abstract][Full Text] [Related]
7. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
Yew B; Nation DA;
Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
[TBL] [Abstract][Full Text] [Related]
8. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.
Mattsson N; Tosun D; Insel PS; Simonson A; Jack CR; Beckett LA; Donohue M; Jagust W; Schuff N; Weiner MW;
Brain; 2014 May; 137(Pt 5):1550-61. PubMed ID: 24625697
[TBL] [Abstract][Full Text] [Related]
9. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
Kurz C; Walker L; Rauchmann BS; Perneczky R
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
[TBL] [Abstract][Full Text] [Related]
10. Cognitive dispersion is elevated in amyloid-positive older adults and associated with regional hypoperfusion.
Holmqvist SL; Thomas KR; Edmonds EC; Calcetas A; Edwards L; Bangen KJ;
J Int Neuropsychol Soc; 2023 Aug; 29(7):621-631. PubMed ID: 36093903
[TBL] [Abstract][Full Text] [Related]
11. Imaging subtle leaks in the blood-brain barrier in the aging human brain: potential pitfalls, challenges, and possible solutions.
Montagne A; Barnes SR; Nation DA; Kisler K; Toga AW; Zlokovic BV
Geroscience; 2022 Jun; 44(3):1339-1351. PubMed ID: 35469116
[TBL] [Abstract][Full Text] [Related]
12. The Vascular Hypothesis of Alzheimer's Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging.
de la Torre J
J Alzheimers Dis; 2018; 63(1):35-52. PubMed ID: 29614675
[TBL] [Abstract][Full Text] [Related]
13. Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome.
Neale N; Padilla C; Fonseca LM; Holland T; Zaman S
Neuroimage Clin; 2018; 17():263-271. PubMed ID: 29159043
[TBL] [Abstract][Full Text] [Related]
14. The Whole Picture: From Isolated to Global MRI Measures of Neurovascular and Neurodegenerative Disease.
Dickie DA; Quinn TJ; Dawson J
Adv Exp Med Biol; 2019; 1205():25-53. PubMed ID: 31894568
[TBL] [Abstract][Full Text] [Related]
15. Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementia.
Román G; Pascual B
Arch Med Res; 2012 Nov; 43(8):671-6. PubMed ID: 23142262
[TBL] [Abstract][Full Text] [Related]
16. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.
Nelson AR; Sweeney MD; Sagare AP; Zlokovic BV
Biochim Biophys Acta; 2016 May; 1862(5):887-900. PubMed ID: 26705676
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer's disease with an implantable ultrasound device.
Epelbaum S; Burgos N; Canney M; Matthews D; Houot M; Santin MD; Desseaux C; Bouchoux G; Stroer S; Martin C; Habert MO; Levy M; Bah A; Martin K; Delatour B; Riche M; Dubois B; Belin L; Carpentier A
Alzheimers Res Ther; 2022 Mar; 14(1):40. PubMed ID: 35260178
[TBL] [Abstract][Full Text] [Related]
18. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
[TBL] [Abstract][Full Text] [Related]
19. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
[TBL] [Abstract][Full Text] [Related]
20. Water-exchange MRI detects subtle blood-brain barrier breakdown in Alzheimer's disease rats.
Dickie BR; Vandesquille M; Ulloa J; Boutin H; Parkes LM; Parker GJM
Neuroimage; 2019 Jan; 184():349-358. PubMed ID: 30219292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
